These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 12431845)

  • 1. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.
    Bymaster FP; Katner JS; Nelson DL; Hemrick-Luecke SK; Threlkeld PG; Heiligenstein JH; Morin SM; Gehlert DR; Perry KW
    Neuropsychopharmacology; 2002 Nov; 27(5):699-711. PubMed ID: 12431845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat.
    Swanson CJ; Perry KW; Koch-Krueger S; Katner J; Svensson KA; Bymaster FP
    Neuropharmacology; 2006 May; 50(6):755-60. PubMed ID: 16427661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.
    Koda K; Ago Y; Cong Y; Kita Y; Takuma K; Matsuda T
    J Neurochem; 2010 Jul; 114(1):259-70. PubMed ID: 20403082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats.
    Ruocco LA; Carnevale UA; Treno C; Sadile AG; Melisi D; Arra C; Ibba M; Schirru C; Carboni E
    Behav Brain Res; 2010 Jun; 210(1):99-106. PubMed ID: 20156489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex.
    Horner WE; Johnson DE; Schmidt AW; Rollema H
    Eur J Pharmacol; 2007 Mar; 558(1-3):96-7. PubMed ID: 17198700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study.
    Koch S; Perry KW; Nelson DL; Conway RG; Threlkeld PG; Bymaster FP
    Neuropsychopharmacology; 2002 Dec; 27(6):949-59. PubMed ID: 12464452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Towards an understanding of the molecular mechanisms underlying the pharmacological treatments of attention deficit hyperactivity disorder].
    Castellanos FX; Acosta MT
    Rev Neurol; 2011 Mar; 52 Suppl 1():S155-60. PubMed ID: 21365598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of the norepinephrine and dopamine reuptake inhibitor EB-1020: implications for treatment of attention-deficit hyperactivity disorder.
    Bymaster FP; Golembiowska K; Kowalska M; Choi YK; Tarazi FI
    Synapse; 2012 Jun; 66(6):522-32. PubMed ID: 22298359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum.
    Li XM; Perry KW; Wong DT; Bymaster FP
    Psychopharmacology (Berl); 1998 Mar; 136(2):153-61. PubMed ID: 9551772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: potential relevance to attention deficit hyperactivity disorder.
    Schmeichel BE; Zemlan FP; Berridge CW
    Neuropharmacology; 2013 Jan; 64(1):321-8. PubMed ID: 22796428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of serotonin-norepinephrine reuptake inhibitors on locomotion and prefrontal monoamine release in spontaneously hypertensive rats.
    Umehara M; Ago Y; Fujita K; Hiramatsu N; Takuma K; Matsuda T
    Eur J Pharmacol; 2013 Feb; 702(1-3):250-7. PubMed ID: 23376565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prepuberal intranasal dopamine treatment in an animal model of ADHD ameliorates deficient spatial attention, working memory, amino acid transmitters and synaptic markers in prefrontal cortex, ventral and dorsal striatum.
    Ruocco LA; Treno C; Gironi Carnevale UA; Arra C; Mattern C; Huston JP; de Souza Silva MA; Nikolaus S; Scorziello A; Nieddu M; Boatto G; Illiano P; Pagano C; Tino A; Sadile AG
    Amino Acids; 2014 Sep; 46(9):2105-22. PubMed ID: 24862315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal.
    Devoto P; Flore G; Pira L; Diana M; Gessa GL
    Psychopharmacology (Berl); 2002 Mar; 160(2):220-4. PubMed ID: 11875641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atomoxetine-induced increases in monoamine release in the prefrontal cortex are similar in spontaneously hypertensive rats and Wistar-Kyoto rats.
    Ago Y; Umehara M; Higashino K; Hasebe S; Fujita K; Takuma K; Matsuda T
    Neurochem Res; 2014 May; 39(5):825-32. PubMed ID: 24634253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain.
    Easton N; Steward C; Marshall F; Fone K; Marsden C
    Neuropharmacology; 2007 Feb; 52(2):405-14. PubMed ID: 17020775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat.
    Liu LL; Yang J; Lei GF; Wang GJ; Wang YW; Sun RP
    Basic Clin Pharmacol Toxicol; 2008 Jun; 102(6):527-32. PubMed ID: 18346050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine.
    Tzavara ET; Bymaster FP; Overshiner CD; Davis RJ; Perry KW; Wolff M; McKinzie DL; Witkin JM; Nomikos GG
    Mol Psychiatry; 2006 Feb; 11(2):187-95. PubMed ID: 16231039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of norepinephrine in the control of activity and attentive processes in animal models of attention deficit hyperactivity disorder.
    Viggiano D; Ruocco LA; Arcieri S; Sadile AG
    Neural Plast; 2004; 11(1-2):133-49. PubMed ID: 15303310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of acetaldehyde on nicotine-induced transmitter levels in young and adult brain areas.
    Sershen H; Shearman E; Fallon S; Chakraborty G; Smiley J; Lajtha A
    Brain Res Bull; 2009 Aug; 79(6):458-62. PubMed ID: 19389462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered gene expression in the prefrontal cortex of young rats induced by the ADHD drug atomoxetine.
    Lempp T; Toennes SW; Wunder C; Russe OQ; Möser CV; Kynast KL; Freitag CM; Niederberger E
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():221-8. PubMed ID: 22960082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.